Asymmetric Phenanthroline and Bipyridine Synthesis With Inorganic Bases
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to introduce different substituents to symmetrical positions in 1,10-phenanthroline and 2,2′-bipyridine derivatives efficiently, due to challenges in chemical reactivity and the need for hazardous reagents or costly, low-yield processes.
Innovation Solution
A synthesis method involving the reaction of a 1,10-phenanthroline or 2,2′-bipyridine derivative with an aliphatic cyclic amine using an inorganic base and solvent, such as potassium carbonate or potassium acetate, allows for the introduction of different substituents to symmetrical positions, stabilizing the reaction conditions and enabling high-yield production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional methods are used to introduce different substituents to symmetrical positions in 1,10-phenanthroline and 2,2′-bipyridine derivatives, then the synthesis process becomes complex and costly, but the yield remains low and the process requires hazardous reagents
Solution Approach 1:
The patent changes the chemical parameters of the reaction system by using specific inorganic bases (potassium carbonate, potassium acetate) and controlling reaction conditions (temperature, solvent selection) to achieve high-yield synthesis of asymmetrically substituted phenanthroline and bipyridine derivatives without requiring hazardous reagents or complex multi-step processes
Solution Approach 2:
The patent uses inorganic bases as intermediary substances to facilitate the introduction of different substituents to symmetrical positions. The base acts as a catalyst or reagent that enables the asymmetric substitution reaction to proceed efficiently, avoiding the need for complex protecting groups or multiple sequential reactions
2Reliability
If existing synthesis methods are applied, then the process requires hazardous reagents or costly procedures, but the manufacturing cost increases and safety concerns arise
Solution Approach 1:
The patent replaces expensive and hazardous reagents with inexpensive, safe inorganic bases such as potassium carbonate and potassium acetate. These disposable, non-toxic reagents can be used in stoichiometric or catalytic amounts and do not require special handling or disposal procedures, thereby eliminating safety concerns and reducing manufacturing costs while maintaining reliable synthesis
Solution Approach 2:
The patent converts the potential harm of using strong bases or hazardous reagents into a benefit by selecting mild inorganic bases that are both effective for the substitution reaction and safe for handling. The reaction conditions are optimized to achieve high conversion without requiring dangerous substances, thus turning a potential safety risk into a safe and reliable manufacturing process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the stable and cost-effective synthesis of novel 1,10-phenanthroline and 2,2′-bipyridine derivatives with asymmetric substituents, facilitating the development of advanced organic compounds for electronic devices.
Implementation Method 1
A synthesis method involving the reaction of a 1,10-phenanthroline or 2,2′-bipyridine derivative with an aliphatic cyclic amine using an inorganic base and solvent
Data Source
AI summary
A 1,10-phenanthroline derivative or a 2,2′-bipyridine derivative having different substituents at symmetrical positions is provided. An organic compound represented by General Formula (G1) or General Formula (G2) below is provided. In General Formula (G1) or (G2) below, any one of X2 to X5 or any one of X6 to X9 represents a halogen or a trifluoromethanesulfonyl group, and the others represent hydrogens. Any one of R2 to R5 or any one of R6 to R9 represents an aliphatic cyclic amino group. Note that a carbon to which the halogen or the trifluoromethanesulfonyl group is bonded and a carbon to which the aliphatic cyclic amino group is bonded are at line-symmetrical positions in a main skeleton (a 1,10-phenanthroline skeleton or a 2,2′-bipyridine skeleton).